# Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study

**Authors:** Stefanie Burghaus, Lothar Häberle, Michael G. Schrauder, Katharina Heusinger, Falk C. Thiel, Alexander Hein, David Wachter, Johanna Strehl, Arndt Hartmann, Arif B. Ekici, Stefan P. Renner, Matthias W. Beckmann, Peter A. Fasching

PMC · DOI: 10.1186/s12885-015-1821-9 · BMC Cancer · 2015-10-21

## TL;DR

This study finds that a history of endometriosis may increase the risk of endometrial or ovarian cancer in middle-aged to older women.

## Contribution

The study identifies endometriosis as a potential risk factor for ovarian or endometrial cancer in a hospital-based case–control analysis.

## Key findings

- Endometriosis was reported in 4.8% of cancer cases and 2.1% of controls.
- Endometriosis was a significant predictor of cancer status (OR 2.63; 95% CI, 1.28 to 5.41).

## Abstract

No screening programs are available for ovarian or endometrial cancer. One reason for this is the low incidence of the conditions, resulting in low positive predictive values for tests, which are not very specific. One way of addressing this problem might be to use risk factors to define subpopulations with a higher incidence. The aim of this study was to investigate the extent to which a medical history of endometriosis can serve as a risk factor for ovarian or endometrial cancer.

In a hospital-based case–control analysis, the cases represented patients with endometrial or ovarian cancer who were participating in studies aimed at assessing the risk for these diseases. The controls were women between the age of 40 and 85 who were invited to take part via a newspaper advertisement. A total of 289 cases and 1016 controls were included. Using logistic regression models, it was tested whether self-reported endometriosis is a predictor of case–control status in addition to age, body mass index (BMI), number of pregnancies and previous oral contraceptive (OC) use.

Endometriosis was reported in 2.1 % of the controls (n = 21) and 4.8 % of the cases (n = 14). Endometriosis was a relevant predictor for case–control status in addition to other predictive factors (OR 2.63; 95 % CI, 1.28 to 5.41).

This case–control study found that self-reported endometriosis may be a risk factor for endometrial or ovarian cancer in women between 40 and 85 years. There have been very few studies addressing this issue, and incorporating it into a clinical prediction model would require a more precise characterization of the risk factor of endometriosis.

## Linked entities

- **Diseases:** endometriosis (MONDO:0005133), ovarian cancer (MONDO:0005140), endometrial cancer (MONDO:0002447)

## Full-text entities

- **Genes:** BRCA1 (BRCA1 DNA repair associated) [NCBI Gene 672] {aka BRCAI, BRCC1, BROVCA1, FANCS, IRIS, PNCA4}, BRCA2 (BRCA2 DNA repair associated) [NCBI Gene 675] {aka BRCC2, BROVCA2, FACD, FAD, FAD1, FANCD}, HNF1B (HNF1 homeobox B) [NCBI Gene 6928] {aka ADTKD3, FJHN, HNF-1-beta, HNF-1B, HNF1beta, HNF2}, PCLAF (PCNA clamp associated factor) [NCBI Gene 9768] {aka KIAA0101, L5, NS5ATP9, OEATC, OEATC-1, OEATC1}, BAGE (B melanoma antigen) [NCBI Gene 574] {aka BAGE1, CT2.1}
- **Diseases:** MGS (MESH:C548078), epithelial ovarian cancer (MESH:D000077216), endometrial or invasive epithelial ovarian cancer disease (MESH:D009375), Pelvic pain (MESH:D017699), cancer (MESH:D009369), diabetes (MESH:D003920), hypertension (MESH:D006973), deaths (MESH:D003643), BBCC (MESH:D001943), OC (MESH:D020820), dyschezia (MESH:D003248), dyspareunia (MESH:D004414), endometrial or ovarian cancer (MESH:D004714), clear cell ovarian carcinoma (MESH:D010051), BECS (MESH:D016889), endometriotic implants (MESH:D057873), abdominal pain (MESH:D015746), endometriotic lesions (MESH:D009059), inflammation (MESH:D007249), Lynch syndrome (MESH:D003123), dysuria (MESH:D053159), obesity (MESH:D009765), Endometriosis (MESH:D004715), hemorrhage (MESH:D006470), gynecological diseases (MESH:D005831), ovarian (MESH:D010049)
- **Chemicals:** tamoxifen (MESH:D013629), sphingolipids (MESH:D013107), hormonal contraceptives (-), iron (MESH:D007501), prostaglandins (MESH:D011453), progesterone (MESH:D011374), reactive oxygen species (MESH:D017382), heme (MESH:D006418)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** D1853N
- **Cell lines:** LH — Homo sapiens (Human), Transformed cell line (CVCL_V626)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4618513/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC4618513/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC4618513/full.md

---
Source: https://tomesphere.com/paper/PMC4618513